eslicarbazepine acetate has been researched along with Fatigue in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantu, D; Gama, H; Grinnell, T; Hall, D; Krishnaiengar, SR; Pereira, A | 1 |
| Ben-Menachem, E; Elger, C; Keller, B; Kowacs, PA; Löffler, K; Rocha, JF; Soares-da-Silva, P; Trinka, E | 1 |
| Delanty, N; Holtkamp, M; McMurray, R; Sales, F; Serratosa, J; Villanueva, V | 1 |
| Holtkamp, M; Kockelmann, E; Lendemans, D; Losch, FP; McMurray, R | 1 |
1 review(s) available for eslicarbazepine acetate and Fatigue
| Article | Year |
|---|---|
Eslicarbazepine acetate (aptiom) for epilepsy.
Topics: Animals; Dibenzazepines; Dizziness; Epilepsy; Fatigue; Humans; Prodrugs; Randomized Controlled Trials as Topic | 2014 |
3 trial(s) available for eslicarbazepine acetate and Fatigue
| Article | Year |
|---|---|
Long-term quality of life in patients with focal seizures treated with adjunctive eslicarbazepine acetate.
Topics: Anticonvulsants; Double-Blind Method; Fatigue; Humans; Quality of Life; Seizures; Treatment Outcome | 2023 |
Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study.
Topics: Adult; Alanine Transaminase; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dibenzazepines; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Epilepsies, Partial; Equivalence Trials as Topic; Fatigue; Female; gamma-Glutamyltransferase; Headache; Humans; Logistic Models; Male; Middle Aged; Nausea; Treatment Outcome; Voltage-Gated Sodium Channel Blockers; Young Adult | 2018 |
[Anticonvulsant add-on therapy with Eslicarbazepine acetate : Results of the EPOS-study in adults in Germany].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Causality; Chemotherapy, Adjuvant; Comorbidity; Dibenzazepines; Dizziness; Dose-Response Relationship, Drug; Epilepsy; Fatigue; Female; Germany; Headache; Humans; Male; Middle Aged; Prevalence; Quality of Life; Risk Factors; Treatment Outcome; Voltage-Gated Sodium Channel Blockers; Young Adult | 2016 |
1 other study(ies) available for eslicarbazepine acetate and Fatigue
| Article | Year |
|---|---|
Eslicarbazepine acetate as monotherapy in clinical practice: Outcomes from Euro-Esli.
Topics: Adult; Anticonvulsants; Ataxia; Dibenzazepines; Dizziness; Europe; Fatigue; Female; Humans; Male; Middle Aged; Seizures; Sleepiness; Vertigo | 2019 |